Oral carnitine supplements were well tolerated and blood levels of the molecule increased in people with pulmonary arterial hypertension…
Articles by Andrea Lobo
Treatment with Adempas (riociguat) is generally safe and effective for people with pulmonary arterial hypertension (PAH) and coexisting…
The European Commission has granted orphan medicinal product designation to Cereno Scientific’s CS1 for the treatment of people with…
Winrevair (sotatercept-csrk), Merck’s injection therapy for adults with pulmonary arterial hypertension (PAH), has been approved in the…
The protein asporin was identified as a possible biomarker of disease severity and to be protective in pulmonary arterial…
People with interstitial lung disease face higher healthcare resource utilization (HCRU) and increased medical costs if they are also diagnosed…
Children of cigarette-smoking parents are at greater risk of developing pulmonary arterial hypertension (PHA) within a year after birth,…
Two molecules, 5-hydroxyindoleacetic acid (5-HIAA) and insulin-like growth factor 1 (IGF-1), showed a potential to diagnose pulmonary hypertension early…
Healthcare costs were found to be more than eight times higher for people with pulmonary arterial hypertension (PAH) compared…
Gemcitabine, a chemotherapy given to treat solid cancers, may drive the onset of pulmonary arterial hypertension (PAH) in patients…
Treatment with Revatio (sildenafil) at a higher dose than the recommended and previously approved doses did not significantly increase…
Levels of fractional exhaled nitric oxide (FeNO) — a measure of how much nitric oxide a person exhales — may…